Search results
Results from the WOW.Com Content Network
PCV13 is a series of 4 shots given at 2, 4, and 6 months of age. The last is given between 12 and 15 months of age. Side effects of this vaccine may include: [2] about half the children become drowsy; temporary loss of appetite; redness or tenderness at injection site; 1 in 3 have swelling at injection site; about 1 in 3 have mild fever
According to the U.S. Centers for Disease Control and Prevention, while "any vaccine can cause side effects", [11] most side effects are minor, primarily including sore arms or a mild fever. [11] Unlike most medical interventions vaccines are given to healthy people, where the risk of side effects is not as easily outweighed by the benefit of ...
According to the CDC, people are more likely to develop Guillain-Barre after having influenza than after the vaccine against it, suggesting that a flu shot can reduce risks of both getting an ...
Guillain–Barré syndrome (also called "GBS") is a rapid-onset muscle weakness caused by the immune system damaging the peripheral nervous system. [3] Typically, both sides of the body are involved, and the initial symptoms are changes in sensation or pain often in the back along with muscle weakness, beginning in the feet and hands, often spreading to the arms and upper body. [3]
Doctors explain the RSV vaccine and its side effects in older adults. ... It also leads to about 58,000 hospitalizations and 500 deaths in children under the age of 5. ... That includes Guillain ...
Reports of a rare nervous system disorder were “more common than expected” in older U.S. adults who got the new RSV vaccines, according to a Centers for Disease Control and Prevention report ...
CDC officials presented similar findings on the RSV shots and Guillain-Barre syndrome at a February public meeting. An estimated 3,000 to 6,000 people develop Guillain-Barre syndrome in the U.S. each year — either after being infected by a virus or linked to a vaccination — and it’s more common in older people, according to the CDC.
Because of similarities between the 2009 influenza A subtype H1N1 virus and the 1976 influenza A/NJ virus many countries established surveillance systems for vaccine-related adverse effects on human health. A possible link between the 2009 H1N1 flu vaccine and Guillain–Barré Syndrome cases was studied in Europe and the United States.